Quince Therapeutics Competitors and Similar CompaniesClear all
Quince Therapeutics's competitors and similar companies include Alector and CSL Behring.
 Quince Therapeutics Quince Therapeutics (formerly known as Cortexyme) is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. | ||
Founding Date | Founding Date 2012 | Founding Date 2013 | Founding Date 1904 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations San Francisco, US HQ | Locations San Francisco, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 2321% increase | Employees 2382% decrease | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 51.1 m | Valuation ($) 495.3 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $21m (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Net income | Net income ($84m) (FY, 2025) | Net income ($142.9m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Patent Applications | Patent Applications N/A | Patent Applications 380 (FY, 2021) | Patent Applications 3 (Dec, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 194.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Alector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View company